Topics

Obesity Research

Injectable diabetes medicine drives down weight, too, research finds

Injectable diabetes medicine drives down weight, too, research finds

The diabetes medication liraglutide helped more than twice as many obese subjects in a clinical trial lose 5% of their body weight, and more than three times as many lose a tenth of their body weight, compared with subjects taking a placebo, according to new research. The drug also appeared to reduce dramatically the risk of developing type-2 diabetes among those taking it. Compared with subjects getting liraglutide, those getting a placebo medication were eight times likelier to be diagnosed with type-2 diabetes during the 12-month trial. The injectable drug, marketed as Saxenda and produced by Novo Nordisk, was approved last December by the U.S. Food & Drug Administration as a...

Loading